The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prevalence of Age-Related Macular Degeneration in Europe
Open accessAbstract
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of European ancestry. Risk profiles and treatment options have changed considerably over the years, which may have affected disease prevalence and outcome. We determined the prevalence of early and late AMD in Europe from 1990 to 2013 using the European Eye Epidemiology (E3) consortium, and made projections for the future. DESIGN: Meta-analysis of prevalence data. PARTICIPANTS: A total of 42 080 individuals 40 years of age and older participating in 14 population-based cohorts from 10 countries in Europe. METHODS: AMD was diagnosed based on fundus photographs using the Rotterdam Classification. Prevalence of early and late AMD was calculated using random-effects meta-analysis stratified for age, birth cohort, gender, geographic region, and time period of the study. Best-corrected visual acuity (BCVA) was compared between late AMD subtypes; geographic atrophy (GA) and choroidal neovascularization (CNV). MAIN OUTCOME MEASURES: Prevalence of early and late AMD, BCVA, and number of AMD cases. RESULTS: Prevalence of early AMD increased from 3.5% (95% confidence interval [CI] 2.1%-5.0%) in those aged 55-59 years to 17.6% (95% CI 13.6%-21.5%) in those aged ≥85 years; for late AMD these figures were 0.1% (95% CI 0.04%-0.3%) and 9.8% (95% CI 6.3%-13.3%), respectively. We observed a decreasing prevalence of late AMD after 2006, which became most prominent after age 70. Prevalences were similar for gender across all age groups except for late AMD in the oldest age category, and a trend was found showing a higher prevalence of CNV in Northern Europe. After 2006, fewer eyes and fewer ≥80-year-old subjects with CNV were visually impaired (P = 0.016). Projections of AMD showed an almost doubling of affected persons despite a decreasing prevalence. By 2040, the number of individuals in Europe with early AMD will range between 14.9 and 21.5 million, and for late AMD between 3.9 and 4.8 million. CONCLUSION: We observed a decreasing prevalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in Europe. Healthier lifestyles and implementation of anti-vascular endothelial growth factor treatment are the most likely explanations. Nevertheless, the numbers of affected subjects will increase considerably in the next 2 decades. AMD continues to remain a significant public health problem among Europeans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 7×
“Our study provides insight into the prevalence of both early and late AMD in Europe.”
MethodInfluentialTHE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES
HALDANE, B. J. B. S. (1956) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01285.x · Cited by 1,076
Prevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Incidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
Self-citationAge-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Prevalence of Age-Related Macular Degeneration in the US Population
Klein, R. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.318 · Cited by 514
Prevalence of Age-Related Maculopathy in Older Europeans: The European Eye Study (EUREYE)
Augood, C. A. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.4.529 · Cited by 390
Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
Bloch, S. B., Larsen, M., & Munch, I. C. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.10.016 · Cited by 377
Boyer, D. S., Heier, J. S., Brown, D. M., Francom, S. F., Ianchulev, T., & Rubio, R. G. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.05.024 · Cited by 347
Rein, D. B. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.58 · Cited by 344
Bourne, R. R. A., Jonas, J. B., Flaxman, S. R., Keeffe, J., Leasher, J., Naidoo, K., Parodi, M. B., Pesudovs, K., Price, H., White, R. A., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304033 · Cited by 341
The estimated prevalence and incidence of late stage age related macular degeneration in the UK
Owen, C. G., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A. E., & Rudnicka, A. R. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301109 · Cited by 319
Self-citationFRIEDMAN, B. (1941) · Archives of Ophthalmology · doi:10.1001/archopht.1941.00870100042005 · Cited by 260
Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review
Prokofyeva, E., & Zrenner, E. (2012) · Ophthalmic Research · doi:10.1159/000329603 · Cited by 212 · cited 1×
“Although multiple small studies have assessed the prevalence of AMD and its relation to visual decline at various places in Europe, a clear overview for Europe as a whole is lacking.(13) Comprehensive epidemiologic figures on AMD in Europe would help proper planning for public health and eye care policy makers.”
BackgroundSelf-citationChange in disability-free life expectancy for Americans 70 years old and older
Crimmins, E. M., Hayward, M. D., Hagedorn, A., Saito, Y., & Brouard, N. (2009) · Demography · doi:10.1353/dem.0.0070 · Cited by 187
Is there a direct association between age-related eye diseases and mortality?
Borger, P. H., van Leeuwen, R., Hulsman, C. A. A., Wolfs, R. C. W., van der Kuip, D. A. M., Hofman, A., & de Jong, P. T. V. M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00450-0 · Cited by 140
Time Trends in the Incidence and Causes of Blindness in Israel
Skaat, A., Chetrit, A., Belkin, M., Kinori, M., & Kalter-Leibovici, O. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.035 · Cited by 115
The Prevalence of Age-Related Maculopathy in Iceland: Reykjavik Eye Study
Jonasson, F. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.3.379 · Cited by 106
Wang, Y. T., Tadarati, M., Wolfson, Y., Bressler, S. B., & Bressler, N. M. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.5332 · Cited by 100
Davies, A. R., Smeeth, L. L., & Grundy, E. M. D. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm272 · Cited by 95
Korb, C. A., Kottler, U. B., Wolfram, C., Höhn, R., Schulz, A., Zwiener, I., Wild, P. S., Pfeiffer, N., & Mirshahi, A. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2591-9 · Cited by 92
Self-citationGrading of age-related maculopathy for epidemiological studies
van Leeuwen, R., Chakravarthy, U., Vingerling, J. R., Brussee, C., Hooghart, A. J., Mulder, P. G. H., & de Jong, P. T. V. M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00501-3 · Cited by 85
Self-citationPrevalence of Age-related Macular Degeneration in Elderly Caucasians: The Tromsø Eye Study
Erke, M. G., Bertelsen, G., Pető, T., Sjølie, A. K., Lindekleiv, H., & Njølstad, I. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.016 · Cited by 77
Self-citationBjörnsson, Ó. M., Syrdalen, P., Bird, A. C., Pető, T., & Kinge, B. (2006) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2006.00696.x · Cited by 56
Self-citationProjected prevalence of age‐related macular degeneration in Scandinavia 2012–2040
Lindekleiv, H., & Erke, M. G. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02399.x · Cited by 56
Self-citationTrends over time and geographical variation in rates of intravitreal injections in England
Keenan, T. D. L., Wotton, C. J., & Goldacre, M. J. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300338 · Cited by 56
Yehoshua, Z., Gregori, G., Sadda, S. R., Penha, F. M., Goldhardt, R., Nittala, M. G., Konduru, R. K., Feuer, W. J., Gupta, P., Li, Y., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11569 · Cited by 51
Prevalence of Age-Related Macular Degeneration in Portugal: The Coimbra Eye Study - Report 1
Cachulo, M. L., Lobo, C. L., Figueira, J., Ribeiro, L., Laíns, I., Vieira, A., Nunes, S. G., Costa, M. A., Simão, S., Rodrigues, V., et al. (2015) · Ophthalmologica · doi:10.1159/000371584 · Cited by 50
Self-citationAge–Period–Cohort Effect on the Incidence of Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Lee, K. E., Gangnon, R. E., & Klein, R. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.01.026 · Cited by 49
Wang, J., Xue, Y., Thapa, S., Wang, L., Tang, J.-F., & Ji, K. (2016) · BioMed Research International · doi:10.1155/2016/8212063 · Cited by 49
Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium
Delcourt, C., Korobelnik, J., Buitendijk, G. H. S., Foster, P. J., Hammond, C. J., Piermarocchi, S., Pető, T., Jansonius, N. M., Mirshahi, A., Hogg, R. E., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0098-2 · Cited by 47
Self-citationEvidence for a considerable decrease in total and cause-specific incidences of blindness in Germany
Claessen, H., Genz, J., Bertram, B., Trautner, C., Giani, G., Zöllner, I., & Icks, A. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9705-7 · Cited by 46
Trends in food consumption over 30 years: evidence from a British birth cohort
Pot, G. K., Prynne, C. J., Almoosawi, S., Kuh, D., Stephen, A. A. M., & teams, T. N. S. A. D. C. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.223 · Cited by 45
Inflammation in Age-Related Macular Degeneration
Ozaki, E., Campbell, M., Kiang, A., Humphries, M. M., Doyle, S., & Humphries, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_30 · Cited by 43
Koch, M. B., Davidsen, M., Andersen, L. V., Juel, K., & Jensen, G. B. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313509495 · Cited by 43
Eight-year trends in food, energy and macronutrient intake in a sample of elderly German subjects
Jungjohann, S. M., Lührmann, P. M., Bender, R., Blettner, M., & Neuhäuser‐Berthold, M. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041333 · Cited by 42
Cachulo, M. L., Laíns, I., Lobo, C. L., Figueira, J., Ribeiro, L., Marques, J. P., Costa, J. C., Vieira, A., Rodrigues, J., Alves, D., et al. (2016) · Acta Ophthalmologica · doi:10.1111/aos.12950 · Cited by 41
Self-citationPlessz, M., Guéguen, A., Goldberg, M., Czernichow, S., & Zins, M. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002615 · Cited by 40
Current status of anti-vascular endothelial growth factor therapy in Europe
Wolf, S. (2008) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-008-0580-4 · Cited by 30
Diffusion of anti-VEGF injections in the Portuguese National Health System
Marques, A. P., Macedo, A. F., Perelman, J., Aguiar, P. M. V., Rocha‐Sousa, A., & Santana, R. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009006 · Cited by 23
McGuinness, M. B., Karahalios, A., Kasza, J., Guymer, R. H., Finger, R. P., & Simpson, J. A. (2017) · Ophthalmic Epidemiology · doi:10.1080/09286586.2016.1276934 · Cited by 20
Self-citationBirth Cohort Effect on Prevalence of Age-related Maculopathy in the Beaver Dam Eye Study
Huang, G. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg011 · Cited by 19
Zunahme der Untersuchungen wegen Katarakt, Glaukom, diabetischer Retinopathie und Makuladegeneration
Bertram, B., Gante, C., & Hilgers, R.-D. (2013) · Der Ophthalmologe · doi:10.1007/s00347-013-2966-z · Cited by 17
Danish Rural Eye Study: Epidemiology of Adult Visual Impairment
Høeg, T. B., Ellervik, C., Buch, H., la Cour, M., Klemp, K., Kvetny, J., Erngaard, D., & Moldow, B. (2016) · Ophthalmic Epidemiology · doi:10.3109/09286586.2015.1066396 · Cited by 12
A Layered Approach to Raising Public Awareness of Macular Degeneration in Australia
Heraghty, J., & Cummins, R. (2012) · American Journal of Public Health · doi:10.2105/ajph.2012.300657 · Cited by 10
Granstam, E., Westborg, I., Barkander, A., Börjesson, M., Lindahl, S., Meszaros, E., Wojciechowska‐Zajac, A., Wagner, P., Albrecht, S., Karlsson, N., et al. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13187 · Cited by 10
Cited by
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Self-citationWallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638
Objectives, design and main findings until 2020 from the Rotterdam Study
Ikram, M. A., Brusselle, G., Ghanbari, M., Goedegebure, A., Ikram, M. K., Kavousi, M., Kieboom, B. C. T., Klaver, C. C. W., de Knegt, R. J., Luik, A. I., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00640-5 · Cited by 452
Self-citationRisk factors for progression of age‐related macular degeneration
Heesterbeek, T. J., Lorés‐Motta, L., Hoyng, C. B., Lechanteur, Y. T. E., & den Hollander, A. I. (2020) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12675 · Cited by 392
Self-citation
Metadata
- Authors
- Colijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G., Bron, A., Anastasopoulos, E., Meester-Smoor, M. A., Segato, T., Piermarocchi, S., de Jong, P. T. V. M., Vingerling, J. R., Topouzis, F., Creuzot-Garcher, C., Bertelsen, G., Pfeiffer, N., Fletcher, A. E., Foster, P. J., Silva, R., Korobelnik, J.-F., Delcourt, C., Klaver, C. C. W., Ajana, S., Arango-Gonzalez, B., Arndt, V., Bhatia, V., Bhattacharya, S. S., Biarnés, M., Borrell, A., Bühren, S., Calado, S. M., Colijn, J. M., Cougnard-Grégoire, A., Dammeier, S., de Jong, E. K., De la Cerda, B., Delcourt, C., den Hollander, A. I., Diaz-Corrales, F. J., Diether, S., Emri, E., Endermann, T., Ferraro, L. L., Garcia, M., Heesterbeek, T. J., Honisch, S., Hoyng, C. B., Kersten, E., Kilger, E., Klaver, C. C. W., Langen, H., Lengyel, I., Luthert, P., Maugeais, C., Meester-Smoor, M., Merle, B. M. J., Monés, J., Nogoceke, E., Peto, T., Pool, F. M., Rodríguez, E., Ueffing, M., Ulrich Bartz-Schmidt, K. U., van Leeuwen, E. M., Verzijden, T., Zumbansen, M., Acar, N., Anastosopoulos, E., Azuara-Blanco, A., Bergen, A., Bertelsen, G., Binquet, C., Bird, A., Brétillon, L., Bron, A., Buitendijk, G., Cachulo, M. L., Chakravarthy, U., Chan, M., Chang, P., Colijn, J., Cougnard-Grégoire, A., Creuzot-Garcher, C., Cumberland, P., Cunha-Vaz, J., Daien, V., Deak, G., Delcourt, C., Delyfer, M.-N., den Hollander, A., Dietzel, M., Erke, M. G., Fauser, S., Finger, R., Fletcher, A., Foster, P., Founti, P., Göbel, A., Gorgels, T., Grauslund, J., Grus, F., Hammond, C., Helmer, C., Hense, H.-W., Hermann, M., Hoehn, R., Hogg, R., Holz, F., Hoyng, C., Jansonius, N., Janssen, S., Khawaja, A., Klaver, C., Korobelnik, J.-F., Lamparter, J., Le Goff, M., Leal, S., Lechanteur, Y., Lehtimäki, T., Lotery, A., Leung, I., Mauschitz, M., Merle, B., Meyer zu Westrup, V., Midena, E., Miotto, S., Mirshahi, A., Mohan-Saïd, S., Mueller, M., Muldrew, A., Nunes, S., Oexle, K., Peto, T., Piermarocchi, S., Prokofyeva, E., Rahi, J., Raitakari, O., Ribeiro, L., Rougier, M.-B., Sahel, J., Salonikiou, A., Sanchez, C., Schmitz-Valckenberg, S., Schweitzer, C., Segato, T., Shehata, J., Silva, R., Silvestri, G., Simader, C., Souied, E., Springelkamp, H., Tapp, R., Topouzis, F., Verhoeven, V., Von Hanno, T., Vujosevic, S., Williams, K., Wolfram, C., Yip, J., Zerbib, J., & Zwiener, I.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 124
- Issue
- 12
- Pages
- 1753-1763
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2734721636
- Cited by
- 486
- References
- 50
- FWCI
- 35.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.